Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
303.50
-4.32 (-1.40%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Ligand Pharmaceuticals Market Cap
Ligand Pharmaceuticals has a market cap or net worth of $6.05 billion as of October 23, 2026. It is the 3,064th most valuable company in the world and the 1,007th biggest in the United States. Its market cap has increased by 65.34% in one year.
Market Cap
6.05B
Enterprise Value
5.82B
1-Year Change
65.34%
Global Rank
Country Rank
#1,007 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Ligand Pharmaceuticals's market cap has increased from $430.80M to $6.05B, an increase of 1,304.47%. That is a compound annual growth rate of 9.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 6.28B | 68.64% |
| Dec 31, 2025 | 3.72B | 83.80% |
| Dec 31, 2024 | 2.02B | 62.58% |
| Dec 29, 2023 | 1.25B | 10.35% |
| Dec 30, 2022 | 1.13B | -56.28% |
| Dec 31, 2021 | 2.58B | 61.30% |
| Dec 31, 2020 | 1.60B | -12.63% |
| Dec 31, 2019 | 1.83B | -36.49% |
| Dec 31, 2018 | 2.88B | -0.20% |
| Dec 29, 2017 | 2.89B | 36.08% |
| Dec 30, 2016 | 2.12B | -1.70% |
| Dec 31, 2015 | 2.16B | 102.78% |
| Dec 31, 2014 | 1.07B | -0.76% |
| Dec 31, 2013 | 1.07B | 159.26% |
| Dec 31, 2012 | 414.10M | 77.34% |
| Dec 30, 2011 | 233.50M | 33.50% |
| Dec 31, 2010 | 174.90M | -28.67% |
| Dec 31, 2009 | 245.20M | -5.73% |
| Dec 31, 2008 | 260.10M | -43.57% |
| Dec 31, 2007 | 460.90M | -46.88% |
| Dec 29, 2006 | 867.60M | 4.96% |
| Dec 30, 2005 | 826.60M | -3.95% |
| Dec 31, 2004 | 860.60M | -19.85% |
| Dec 31, 2003 | 1.07B | 179.68% |
| Dec 31, 2002 | 383.90M | -64.11% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 6.71B |
| Belite Bio | 6.25B |
| Rhythm Pharmaceuticals | 6.25B |
| Immunovant | 5.92B |
| Kodiak Sciences | 5.90B |
| Mirum Pharmaceuticals | 5.54B |
| CG Oncology | 5.52B |
| Cogent Biosciences | 5.43B |